Episode 100: Colorectal Cancer Series, Pt. 2 - Adjuvant Therapy in Stage III Colon Cancer
The Fellow on Call: The Heme/Onc Podcast
00:00
Adjuvant Therapy in High-Risk Colon Cancer
This chapter explores treatment strategies for high-risk stage III colon cancer, particularly N2 disease, emphasizing the findings from the IDEA pooled analysis. It discusses the implications of treatment duration, comparing three months to six months of chemotherapy regimens like Folfox and Kapox, and the impact on patient quality of life. The chapter further examines recent studies that shed light on the effectiveness and potential neurotoxic risks associated with prolonged therapy, encouraging consideration of individual patient circumstances in treatment decisions.
Transcript
Play full episode
